Answers are grounded in this paper and cite their sources.
The disease-associated cell lines used in the majority of preclinical trials should be first authenticated and identified to avoid directing research expenditure on wrong cells and obtaining irrelevant results. The present study evaluated the immunophenotypic and immunotypic authenticity of six human myeloma cell lines (HMCLs).
No takes yet. Share an insight, caveat, or question.
Shiran et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: